GSK to stop selling blood cancer drug Blenrep in US Reuters Nov 23, 2022 The company had said this month that Blenrep had failed the main goal of a key study designed to show it was better than an…
GSK to acquire Sierra Oncology to shore up drug pipeline Reuters Apr 13, 2022 The acquisition is expected to close in the third quarter and will complement Blenrep, GSK’s treatment for another form of blood…
GSK gets USFDA approval for BLENREP to treat relapsed or refractory multiple myeloma EP News Bureau Aug 6, 2020 BLENREP is the fifth major medicine approval for GSK in 2020
